Showing results (121-130 of 190) with videos related to

Sort By:
Pageof 19
Medical Mycology Case Reports|June 18, 2020
Isavuconazonium for the treatment of Purpureocillium lilacinum infection in a patient with pyoderma gangrenosumJulia Accetta, Emily Powell, Erin Boh, et al.
Antimicrobial Agents and Chemotherapy|September 25, 2003
Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United StatesLuis Ostrosky-Zeichner, John H Rex, Peter G Pappas, et al.
BMC Infectious Diseases|December 8, 2017
Impact of inappropriate antifungal therapy according to current susceptibility breakpoints on Candida bloodstream infection mortality, a retrospective analysisMaría Fernanda González-Lara, Pedro Torres-González, Patricia Cornejo-Juárez, et al.
Antimicrobial Agents and Chemotherapy|September 24, 2008
Rationale for reading fluconazole MICs at 24 hours rather than 48 hours when testing Candida spp. by the CLSI M27-A2 standard methodLuis Ostrosky-Zeichner, John H Rex, Michael A Pfaller, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 21, 2020
Rezafungin Versus Caspofungin in a Phase 2, Randomized, Double-blind Study for the Treatment of Candidemia and Invasive Candidiasis: The STRIVE TrialGeorge R Thompson, Alex Soriano, Athanasios Skoutelis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 13, 2016
Isavuconazole Treatment of Cryptococcosis and Dimorphic MycosesGeorge R Thompson, Adrian Rendon, Rodrigo Ribeiro Dos Santos, et al.
Mycoses|April 4, 2018
Isavuconazole for treatment of rare invasive fungal diseasesOliver A Cornely, Kathleen M Mullane, Luis Ostrosky-Zeichner, et al.
Intensive Care Medicine|March 4, 2017
Intensive care medicine research agenda on invasive fungal infection in critically ill patientsMatteo Bassetti, Jose Garnacho-Montero, Thierry Calandra, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 15, 2023
Description of Cryptococcosis Following SARS-CoV-2 Infection: A Disease Survey Through the Mycosis Study Group Education and Research Consortium (MSG-19)Jeremey Walker, Todd McCarty, Gerald McGwin, et al.
Pageof 19